Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
BUGWORKS Research logo

BUGWORKS Research

Recent Finacing

Series B I

Recent Raise

$18M

Bugworks Research is a clinical-stage biopharma developing broad-spectrum antibiotics (dual-target gyrase/topo IV) and adenosine immuno-oncology assets using computational, structural, and medicinal chemistry with proprietary GYROX, DARE, ELUDE platforms.

Founded 2014
Karnataka, India
11-50
Private
bugworksresearch.com

Highlights

Focus Areas

Biotechnology
Health Care
Life Science
Pharmaceutical
Product Research

Recent Investors

University of Tokyo Edge Capital logo
A
Global Brain logo
3one4 Capital logo
I.M Holdings logo
Featherlite logo
Lightrock logo
Defense Threat Reduction Agency logo

Financials

$34.5M

Total Raised

4

Funding rounds

8

Investors


Team

Upgrade to view the team

See the team members at BUGWORKS Research.